{"id":"https://openalex.org/W2149207987","doi":"https://doi.org/10.1186/bcr3655","title":"Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy","display_name":"Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-15","ids":{"openalex":"https://openalex.org/W2149207987","doi":"https://doi.org/10.1186/bcr3655","mag":"2149207987","pmid":"https://pubmed.ncbi.nlm.nih.gov/24887359","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4076636"},"language":"en","primary_location":{"id":"doi:10.1186/bcr3655","doi":"https://doi.org/10.1186/bcr3655","is_oa":true,"landing_page_url":"https://doi.org/10.1186/bcr3655","pdf_url":"https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/bcr3655","source":{"id":"https://openalex.org/S42140187","display_name":"Breast Cancer Research","issn_l":"1465-5411","issn":["1465-5411","1465-542X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2149207987"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/bcr3655","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051110690","display_name":"Marieke A. Vollebergh","orcid":"https://orcid.org/0000-0002-6524-3068","observed_orcids":["https://orcid.org/0000-0002-6524-3068"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marieke A Vollebergh","raw_affiliation_strings":["Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076006564","display_name":"Esther H. Lips","orcid":"https://orcid.org/0000-0003-3488-4935","observed_orcids":["https://orcid.org/0000-0003-3488-4935"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Esther H Lips","raw_affiliation_strings":["Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079501701","display_name":"Petra M. Nederlof","orcid":"https://orcid.org/0000-0002-2358-9765","observed_orcids":["https://orcid.org/0000-0002-2358-9765"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Petra M Nederlof","raw_affiliation_strings":["Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020129085","display_name":"Lodewyk F.A. Wessels","orcid":"https://orcid.org/0000-0002-1656-6995","observed_orcids":["https://orcid.org/0000-0002-1656-6995"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I98358874","display_name":"Delft University of Technology","ror":"https://ror.org/02e2c7k09","country_code":"NL","type":"education","lineage":["https://openalex.org/I98358874"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lodewyk FA Wessels","raw_affiliation_strings":["Department of Molecular Carcinogenesis, the Netherlands Cancer Institute -Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Stevinweg 1, 2628 CN, Delft, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Carcinogenesis, the Netherlands Cancer Institute -Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Stevinweg 1, 2628 CN, Delft, The Netherlands","institution_ids":["https://openalex.org/I98358874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020517461","display_name":"Jelle Wesseling","orcid":"https://orcid.org/0000-0002-8940-2676","observed_orcids":["https://orcid.org/0000-0002-8940-2676"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jelle Wesseling","raw_affiliation_strings":["Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062981502","display_name":"Marc J. van de Vijver","orcid":"https://orcid.org/0000-0002-0385-4787","observed_orcids":["https://orcid.org/0000-0002-0385-4787","https://orcid.org/0000-0002-2341-3698"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc J vd Vijver","raw_affiliation_strings":["Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061495577","display_name":"Elisabeth G.E. de Vries","orcid":"https://orcid.org/0000-0002-8949-7425","observed_orcids":["https://orcid.org/0000-0002-8949-7425"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisabeth GE de Vries","raw_affiliation_strings":["Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031176507","display_name":"Harm van Tinteren","orcid":"https://orcid.org/0000-0002-4626-8702","observed_orcids":["https://orcid.org/0000-0002-4626-8702"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harm van Tinteren","raw_affiliation_strings":["Department of Biometrics, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biometrics, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061340130","display_name":"Jos Jonkers","orcid":"https://orcid.org/0000-0002-9264-9792","observed_orcids":["https://orcid.org/0000-0002-9264-9792"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jos Jonkers","raw_affiliation_strings":["Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041206659","display_name":"Michael Hauptmann","orcid":"https://orcid.org/0000-0001-8539-0148","observed_orcids":["https://orcid.org/0000-0001-8539-0148"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Hauptmann","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111726498","display_name":"Sjoerd Rodenhuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sjoerd Rodenhuis","raw_affiliation_strings":["Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063917865","display_name":"Sabine C. Linn","orcid":"https://orcid.org/0000-0001-5541-0347","observed_orcids":["https://orcid.org/0000-0001-5541-0347"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sabine C Linn","raw_affiliation_strings":["Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5063917865"],"corresponding_institution_ids":["https://openalex.org/I2898336195","https://openalex.org/I3018483916"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":5.7017,"has_fulltext":true,"cited_by_count":119,"citation_normalized_percentile":{"value":0.96935918,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"16","issue":"3","first_page":"R47","last_page":"R47"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.8939999938011169},{"id":"https://openalex.org/keywords/brca1-mutation","display_name":"BRCA1 mutation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/brca2-mutation","display_name":"BRCA2 mutation","score":1.0},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.6480000019073486},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.7760000228881836},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.8659999966621399},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.7039999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.8898051977157593},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8447225093841553},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6857579350471497},{"id":"https://openalex.org/C2909462720","wikidata":"https://www.wikidata.org/wiki/Q421651","display_name":"BRCA2 Protein","level":5,"score":0.6243297457695007},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5639277696609497},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5519700050354004},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5508697628974915},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5063508749008179},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.358257919549942},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33448225259780884},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3243330121040344},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.294552743434906},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2803500294685364},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22971472144126892},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.21671754121780396},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20993119478225708},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.1314486265182495}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004260","descriptor_name":"DNA Repair","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013852","descriptor_name":"Thiotepa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019313","descriptor_name":"BRCA1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D024682","descriptor_name":"BRCA2 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D053903","descriptor_name":"DNA Breaks, Double-Stranded","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055028","descriptor_name":"Comparative Genomic Hybridization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059765","descriptor_name":"Homologous Recombination","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1186/bcr3655","doi":"https://doi.org/10.1186/bcr3655","is_oa":true,"landing_page_url":"https://doi.org/10.1186/bcr3655","pdf_url":"https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/bcr3655","source":{"id":"https://openalex.org/S42140187","display_name":"Breast Cancer Research","issn_l":"1465-5411","issn":["1465-5411","1465-542X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4076636","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4076636/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Res","raw_type":"Text"},{"id":"pmid:24887359","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24887359","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer research : BCR","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/1edaa0d1-5a35-479a-912a-fd4685bbfb7f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/1edaa0d1-5a35-479a-912a-fd4685bbfb7f","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vollebergh, M A, Lips, E H, Nederlof, P M, Wessels, L F A, Wesseling, J, Vd Vijver, M J, de Vries, E G E, van Tinteren, H, Jonkers, J, Hauptmann, M, Rodenhuis, S & Linn, S C 2014, 'Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy', Breast cancer research, vol. 16, no. 3, pp. R47. https://doi.org/10.1186/bcr3655","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire/0956160b-7b04-4cc8-ad6f-2b3267c121ba","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/0956160b-7b04-4cc8-ad6f-2b3267c121ba","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vollebergh, M A, Lips, E H, Nederlof, P M, Wessels, L F A, Wesseling, J, Vijver, M J V, de Vries, E G E, van Tinteren, H, Jonkers, J, Hauptmann, M, Rodenhuis, S & Linn, S C 2014, 'Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy', Breast cancer research, vol. 16, no. 3, 47. https://doi.org/10.1186/bcr3655","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/e2a08ede-efd8-454e-a38a-e2fd1f52ac1b","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/genomic-patterns-resembling-brca1-and-brca2mutated-breast-cancers-predict-benefit-of-intensified-carboplatinbased-chemotherapy(e2a08ede-efd8-454e-a38a-e2fd1f52ac1b).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Breast cancer research, 16(3). BioMed Central","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:tudelft.nl:uuid:5f9d8918-4f1b-4dbb-92cf-937ba2a70a9c","doi":null,"is_oa":true,"landing_page_url":"http://resolver.tudelft.nl/uuid:5f9d8918-4f1b-4dbb-92cf-937ba2a70a9c","pdf_url":null,"source":{"id":"https://openalex.org/S4306400906","display_name":"Research Repository (Delft University of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98358874","host_organization_name":"Delft University of Technology","host_organization_lineage":["https://openalex.org/I98358874"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"journal article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/0956160b-7b04-4cc8-ad6f-2b3267c121ba","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/0956160b-7b04-4cc8-ad6f-2b3267c121ba","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Breast cancer research, 16(3):47. BioMed Central Ltd.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1186/bcr3655","doi":"https://doi.org/10.1186/bcr3655","is_oa":true,"landing_page_url":"https://doi.org/10.1186/bcr3655","pdf_url":"https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/bcr3655","source":{"id":"https://openalex.org/S42140187","display_name":"Breast Cancer Research","issn_l":"1465-5411","issn":["1465-5411","1465-542X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3052533721","display_name":null,"funder_award_id":"030-104","funder_id":"https://openalex.org/F4320323596","funder_display_name":"Center for Translational Molecular Medicine"}],"funders":[{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"},{"id":"https://openalex.org/F4320323596","display_name":"Center for Translational Molecular Medicine","ror":"https://ror.org/047wvvg23"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2149207987.pdf","grobid_xml":"https://content.openalex.org/works/W2149207987.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1515564094","https://openalex.org/W1523531555","https://openalex.org/W1583886228","https://openalex.org/W1961026612","https://openalex.org/W1966267239","https://openalex.org/W1973268287","https://openalex.org/W1973560717","https://openalex.org/W1976927712","https://openalex.org/W1992661182","https://openalex.org/W1993763223","https://openalex.org/W1996301092","https://openalex.org/W2005104372","https://openalex.org/W2009007206","https://openalex.org/W2014599726","https://openalex.org/W2024604197","https://openalex.org/W2032487024","https://openalex.org/W2065022250","https://openalex.org/W2066882336","https://openalex.org/W2074565257","https://openalex.org/W2087958851","https://openalex.org/W2098503539","https://openalex.org/W2100554541","https://openalex.org/W2110017381","https://openalex.org/W2113499049","https://openalex.org/W2115581335","https://openalex.org/W2127985028","https://openalex.org/W2128985829","https://openalex.org/W2131563592","https://openalex.org/W2133258471","https://openalex.org/W2142486051","https://openalex.org/W2142491513","https://openalex.org/W2143596381","https://openalex.org/W2150133682","https://openalex.org/W2151864343","https://openalex.org/W2156077962","https://openalex.org/W2157653381","https://openalex.org/W2157693315","https://openalex.org/W2157840751","https://openalex.org/W2160113753","https://openalex.org/W2166237570","https://openalex.org/W2166572860","https://openalex.org/W2167779518","https://openalex.org/W2168409298","https://openalex.org/W2169790254","https://openalex.org/W2171972386","https://openalex.org/W2207221522","https://openalex.org/W2320733832","https://openalex.org/W2323254708","https://openalex.org/W3093265161"],"related_works":["https://openalex.org/W2559852197","https://openalex.org/W2332089684","https://openalex.org/W2133258471","https://openalex.org/W2093419217","https://openalex.org/W2150133682","https://openalex.org/W2528196425","https://openalex.org/W2322527655","https://openalex.org/W2067430510","https://openalex.org/W4404756107","https://openalex.org/W2593080951"],"abstract_inverted_index":{"INTRODUCTION:":[0],"BRCA-mutated":[1],"breast":[2,60,66,85,102,106,134,147],"cancer":[3,67,107],"cells":[4],"lack":[5],"the":[6],"DNA-repair":[7],"mechanism":[8],"homologous":[9],"recombination":[10,22],"that":[11,95,117,211],"is":[12],"required":[13],"for":[14,215],"error-free":[15],"DNA":[16,29],"double-strand":[17],"break":[18],"(DSB)":[19],"repair.":[20],"Homologous":[21],"deficiency":[23],"(HRD)":[24],"may":[25],"cause":[26],"hypersensitivity":[27],"to":[28,77,120,132,195,209,227],"DSB-inducing":[30,122],"agents,":[31],"such":[32],"as":[33,62,111,113,143,151,157],"bifunctional":[34],"alkylating":[35],"agents":[36],"and":[37,47,69,262],"platinum":[38],"salts.":[39],"HRD":[40,79],"can":[41,104],"be":[42],"caused":[43],"by":[44,48],"BRCA":[45],"mutations,":[46],"other":[49],"mechanisms.":[50],"To":[51],"identify":[52,78,105],"HRD,":[53],"studies":[54],"have":[55,87],"focused":[56],"on":[57],"triple-negative":[58],"(TN)":[59],"cancers":[61,86,103,148],"these":[63],"resemble":[64],"BRCA1-mutated":[65],"closely":[68],"might":[70],"also":[71],"share":[72],"this":[73],"hypersensitivity.":[74],"However,":[75],"ways":[76],"in":[80,166],"non-BRCA-mutated,":[81],"estrogen":[82],"receptor":[83],"(ER)-positive":[84],"remained":[88],"elusive.":[89],"The":[90],"current":[91],"study":[92],"provides":[93],"evidence":[94],"genomic":[96,127],"patterns":[97,142,242],"resembling":[98],"BRCA1-":[99,144],"or":[100],"BRCA2-mutated":[101,146],"patients":[108,160,183,216,246],"with":[109,137,139,184,217,247,255],"TN":[110],"well":[112],"ER-positive,":[114],"HER2-negative":[115,245],"tumors":[116,138,186,219,236],"are":[118],"sensitive":[119],"intensified,":[121],"chemotherapy.":[123,180],"METHODS:":[124],"Array":[125],"comparative":[126],"hybridization":[128],"(aCGH)":[129],"was":[130,197,212],"used":[131],"classify":[133],"cancers.":[135],"Patients":[136],"similar":[140],"aCGH":[141,241],"and/or":[145],"were":[149,237],"defined":[150],"having":[152],"a":[153,167,189,248],"BRCA-likeCGH":[154,185,235],"status,":[155],"others":[156],"non-BCRA-likeCGH.":[158],"Stage-III":[159],"(n":[161],"=":[162,230],"249)":[163],"had":[164],"participated":[165],"randomized":[168],"controlled":[169],"trial":[170],"of":[171,192,233],"adjuvant":[172,253],"high-dose":[173],"(HD)":[174],"cyclophosphamide-thiotepa-carboplatin":[175],"(CTC)":[176],"versus":[177],"5-fluorouracil-epirubicin-cyclophosphamide":[178],"(FE90C)":[179],"RESULTS:":[181],"Among":[182],"(81/249,":[187],"32%),":[188],"significant":[190],"benefit":[191,265],"HD-CTC":[193],"compared":[194],"FE90C":[196],"observed":[198],"regarding":[199],"overall":[200],"survival":[201],"(adjusted":[202,220],"hazard":[203,221],"ratio":[204,222],"0.19,":[205],"95%":[206,224],"CI:":[207,225],"0.08":[208],"0.48)":[210],"not":[213],"seen":[214],"non-BRCA-likeCGH":[218],"0.90,":[223],"0.53":[226],"1.54)":[228],"(P":[229],"0.004).":[231],"Half":[232],"all":[234],"ER-positive.":[238],"CONCLUSIONS:":[239],"Distinct":[240],"differentiated":[243],"between":[244],"markedly":[249],"improved":[250],"outcome":[251],"after":[252],"treatment":[254],"an":[256],"intensified":[257],"DNA-DSB-inducing":[258],"regimen":[259],"(BRCA-likeCGH":[260],"patients)":[261],"those":[263],"without":[264],"(non-BRCA-likeCGH":[266],"patients).":[267]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2149207987","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
